Location History:
- Rochester, MN (US) (1987 - 2002)
- Salt Lake City, UT (US) (2005 - 2023)
Company Filing History:
10 out of 1,746 
5 out of 1,644 
3 out of 576 
Years Active: 1987-2023
Title: Gerald J Gleich: Innovating in Eosinophil Research
Introduction
Gerald J Gleich, based in Rochester, MN, is a prominent inventor in the field of medical research, holding an impressive portfolio of 21 patents. His contributions primarily focus on eosinophilic disorders, which have significant implications for understanding respiratory diseases and related conditions.
Latest Patents
Among his latest innovations, Gleich has developed a patented method for detecting eosinophil degranulation in the respiratory tract. This groundbreaking approach involves administering radiolabeled heparin into the respiratory tract, enabling the identification of eosinophil granule proteins that indicate degranulation activities. Additionally, he has patented methods for diagnosing and monitoring eosinophilic esophagitis. These methods leverage the detection of eosinophil granule proteins in the mucosal tissue of the esophagus, allowing for improved diagnostic capabilities and treatment monitoring.
Career Highlights
Gleich has had a distinguished career, contributing his expertise at institutions such as the Mayo Foundation for Medical Education and Research, and the University of Utah Research Foundation. His work has had a profound impact on the understanding and management of complex eosinophilic diseases, emphasizing the importance of innovative diagnostic and treatment strategies.
Collaborations
Throughout his career, Gerald J Gleich has collaborated with notable colleagues including Leonard F Pease and Hedieh Saffari. These partnerships have played a critical role in enhancing research outcomes and advancing the understanding of eosinophilic disorders.
Conclusion
Gerald J Gleich's continued innovations and insights into eosinophilic disorders are paving the way for significant advancements in medical diagnostics and treatment. His extensive patent portfolio reflects his commitment to advancing healthcare through innovative solutions, ultimately improving patient outcomes and enhancing our understanding of complex medical conditions.